KRT5 and neoplasm: Since the expression of both CK5 and CK7, within different areas of the tumor, is characteristic of ASC we double stained LUCA22 and LUCA35 CSLC monolayers for CK5 and CK7 using rhodamine or FITC labeled antibodies.